ArticleFrontiers in medicine2026
Development and internal validation of a nomogram and machine-learning models for postoperative recurrence in adult patients with chronic rhinosinusitis with nasal polyps.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Practical preoperative tools for estimating postoperative recurrence in chronic rhinosinusitis with nasal polyps (CRSwNP) remain limited. We developed and internally validated a conventional nomogram and multiple machine-learning models and evaluated the systemic coagulation-inflammation index (SCI) as a deterministic nonlinear composite of routine laboratory measurements. Methods: The analysis included 245 adults. To preserve the integrity of the originally locked internal validation, the original outcome-stratified assignments were retained after age exclusions, leaving 170 patients in the training set and 75 in the same-center internal held-out set. Centered VIFs were calculated with an intercept, component-versus-composite SCI models were compared, and ten algorithms were tuned by five-fold stratified cross-validation in the training set. A Firth logistic sensitivity analysis forced hypertension and diabetes into the primary model. Results: Recurrence occurred in 95/245 patients (38.8%). SCI was the only initial candidate with VIF > 10 (10.259); after its structural exclusion, all remaining VIFs were ≤1.515. In the five-variable multivariable screening model, WBC was inversely associated with recurrence (OR 0.437, 95% CI 0.307-0.623), whereas PLT (OR 1.024, 95% CI 1.013-1.035) and FIB (OR 4.480, 95% CI 2.346-8.557) were positively associated (all Conclusion: A nomogram based on WBC, PLT, and FIB showed promising same-center internal performance in adults. SCI should be interpreted as a deterministic nonlinear composite rather than unique biological information. External validation in cohorts with standardized tissue histopathology and comprehensive comorbidity data is required before clinical use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.